Paraguay Medical Device Registration 2026: Free Sale Certificate (CLV) Requirements

1. Key takeaways

1. Article 6, item d) requires a free sale certificate (Certificado de Libre Venta, CLV), a registration certificate, or an equivalent document, issued by the competent authority of the country of manufacture and/or the country of sale.
2. Content requirement: the document must contain a detailed description of the product and its models, where applicable.
3. Validity rule: where the document does not expressly state a validity period, it is deemed valid for 2 years from the date of issuance.
4. The operating instructions add that the models, generic names, trademarks and accessories declared on the platform must match the CLV; where the CLV does not state them, a statement, technical documentation, catalogue or clarification letter issued by the manufacturer must be submitted separately.
5. In effect the CLV sets the ceiling of what can be declared on the platform: anything absent from it must be rescued by manufacturer documentation, which is why its content should be fixed before the application is drafted.

2. Legal basis

The two instruments operate together: the resolution defines what the CLV must be and who may issue it, while the operating instructions bind the platform declaration fields on page 4, covering the model field and the accessory details field, to the content of the CLV submitted with the dossier. The CLV is the bridge between the foreign regulatory world and the Paraguayan file: it names the product as it is marketed abroad, and every field that describes the product on DINAVISAPy is measured against it. Preparing it correctly is consequently a data-alignment exercise as much as a documentary one, and the alignment work should start while the CLV is still being requested abroad, not after it arrives.

3. Expert insights

Insight one: the CLV is the anchor of the model list, and any inconsistency triggers cascading errors. The operating instructions require the models declared on the platform to be entered according to the CLV, and the same applies to accessory information. If the CLV names only the product without listing its models, every downstream field must be rescued by supplementary manufacturer documentation, and the probability of an inconsistency surfacing during review rises sharply. The economical solution is to obtain a CLV that enumerates all models and their detailed descriptions at the moment of issuance, so that the platform entries can be transcribed from a single authoritative source. Because the CLV is issued abroad, correcting a model gap means restarting the foreign issuing process from the beginning, which in practice costs more time than obtaining the certificate correctly at first request.

Insight two: the 2-year default validity rule sits in structural tension with the evaluation timeline. The statutory evaluation period for the full analysis route is 120 business days, and once rectification rounds are stacked on top, the span from submission to issuance can approach two years (practical estimate). Article 8 of the operating instructions requires documents to remain valid at the moment of issuance, so a CLV freshly obtained at submission may not survive until the certificate is granted. The workable approach is to reserve one CLV renewal inside the project schedule, with the renewal triggered by a countdown against the expected issuance date rather than by the calendar alone. The countdown must also respect any validity period that the issuing authority does state, since a stated validity shorter than 2 years overrides the default rule and shortens the usable window further.

Insight three: manufacturers in China, Hong Kong, China; Macao, China; Taiwan, China and other non-Latin American jurisdictions must confirm early who can issue the CLV-equivalent document. The resolution accepts a registration certificate or an equivalent document, meaning that a free sale certificate is not the only acceptable form. Whether the corresponding document issued in the Chinese mainland would be accepted, and whether it must be issued at the provincial or the national level, is a matter of practical estimate; the issuing route must be confirmed with the local regulatory contact during project initiation, so that the application is never addressed to the wrong issuing body. The written confirmation should record which document was accepted, on what legal basis, and by whom, so that the acceptance rationale survives staff turnover and later audit questions.

4. Practical recommendations

1. When applying for the CLV, expressly require that it state all models declared for registration, including specification variants, and not just the product name; a CLV that names only the product generically forces every model onto supplementary documents and multiplies the points of inconsistency.
2. Set up a CLV expiry alert: count backwards from the expected issuance date, and renew early wherever the remaining margin is under 2 years.
3. Before completing the platform fields, run an item-by-item comparison between the CLV and every corresponding field, and cover any missing element with a manufacturer clarification letter, so that missing elements are known before the application is filed rather than raised by the reviewer weeks later.
4. Confirm the acceptability of documents issued in the Chinese mainland or other non-treaty jurisdictions with the local regulatory contact in advance, and keep a written record of that confirmation in the project file.

5. Verification checklist

• □ CLV states all declared models with detailed descriptions
• □ CLV issued by the competent authority of the country of manufacture or of sale
• □ Validity counted backwards from the expected issuance date (2 years where none is stated)
• □ Platform fields compared against the CLV item by item
• □ Acceptability of documents issued in the Chinese mainland confirmed in writing by the local contact

Regulatory information verified as of October 29, 2026.

GRZAN provides registration and conformity support in Paraguay for medical device manufacturers, importers and authorized representatives, including CLV strategy, model alignment and DINAVISAPy submission management. For assistance, contact info@grzanglobal.com.